논문실적
Home › 연구실적 › 논문실적
- 230Phase II study of S-1 and oxaliplatin for patients with metastatic biliary tract cancer: influence of CYP2A6 polymorphism on pharmacokinetics and clinical activity.
Kim KP, Jang G, Hong YS, Lim HS, Bae KS, Kim HS, Lee SS, Shin JG, Lee JL, Ryu MH, Chang HM, Kang YK, Kim TW. · Br J Cancer. 104(4):605-12 / 2011.02 · 2011-International PRCDM
- 229Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.
Choi MK, Shin HJ, Choi YL, Deng JW, Shin JG, Song IS. · Xenobiotica 41(1):24-34 / 2011.01 · 2011-International
- 228Genetic variations in UDP-glucurosyltransferase 2B7 gene (UGT2B7) in a Korean population
Hwang MS, Lee SJ, Jeong HE, Lee SS, Yoo MA, Shin JG · Drug Metab Pharmacokinet. 25(4):398-402 / 2010.09 · 2010-International BMRC, PRCDM
- 227A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients
Lee SJ, Jang YJ, Cha EY, Kim HS, Lee SS, Shin JG · Br J Clin Pharmacol. 70(2):213-21. / 2010.08 · 2010-International BMRC, PRCDM
- 226Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
Kim H, Bae SK, Park SJ, Shim EJ, Kim HS, Shon JH, Liu KH, Shin JG · Br J Clin Pharmacol. 70(1):126-31 / 2010.07 · 2010 BMRC, PRCDM
- 225Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing
Lenzini P, Wadelius M, ... Shin J, Kim H, ... Berg RL, Deloukas P, Gage BF. · Clin Pharmacol Ther. 87(5):572-8 / 2010.05 · 2010-International PRCDM
- 224Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across three racial groups.
Limdi NA, Wadelius M, ~ Pirmohamed M, Shin JG, ~ Klein TE, Wagner MJ · Blood 115(18):3827-34 / 2010.05 · 2010-International BMRC, PRCDM
- 223Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters.
Shin HJ, Lee CH, Park SJ, Shin JG, Song IS · Arch Pharm Res. 33(5):709-16 / 2010.05 · 2010 PRCDM, 연구교수
- 222Identification of CYP19A1 single nucleotide polymorphisms and their haplotype distributions in a Korean population
Lee SJ, Kim WY, Choi JY, Lee SS, Shin JG. · J Hum Genet. 55(3):189-93 / 2010.03 · 2010 BMRC, PRCDM
- 221Robust CYP2D6 Genotype Assay including Copy Number Variation using Multiplex Single-Base Extension for Asian Populations
Kim EY, Lee SS, Jung HJ, Jung HE, Yeo CW, Shon JH, Shin JG · Clin Chim Acta. 411(23-24):2043-8 · 2010-International BMRC, PRCDM
- 220The metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7.
Seo KA, Bae SK, Choi YK, Choi CS, Liu KH, Shin JG. · Drug Metab Dispos. 38(11):2007-13 · 2010-International BMRC, PRCDM
- 219Significantly the Disposition and Antihistamine Effect of Ebastine and Its Metabolites in Healthy Participants
Shon JH, Yeo CW, Liu KH, Lee SS, Cha IJ, Shin JG · J Clin Pharmacol. 50(2):195-204 · 2010-International BMRC, PRCDM
- 218Murrayafoline A attenuates the Wnt/beta-catenin pathway by promoting the degradation of intracellular beta-catenin proteins.
Choi H, Gwak J, Cho M, Ryu MJ, Lee JH, Kim SK, Kim YH, Lee GW, Yun MY, Cuong NM, Shin JG, Song GY, Oh S. · Biochem Biophys Res Commun. 391(1):915-20 · 2010-International
- 217Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population
Lee SS, Jung HJ, Park JS, Cha IJ, Cho DY, Shin JG · Mol Biol Rep. 37(1):213-7 · 2010-International BMRC
- 216Identification of genetic polymorphisms of human OAT1 and OAT2 genes and their relationship to hOAT2 expression in human liver
Shin HJ, Lee CH, Lee SS, Song IS, Shin JG · Clinica Chimica Acta 411(1-2):99-105 · 2010-International BMRC, 수송체